Provista Diagnostics, Inc. develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. Our focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near term development and commercialization efforts focus on women’s cancers such as breast and ovarian cancer, as well as early detection testing for lung cancer.

Provista Diagnostic’s technologies are developed at our CLIA compliant, 14,600 sq/ft laboratory facility based in Phoenix, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.

For more information please contact us